Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Projected $20 Mil. In 2013 Biosimilar User Fees Translates Into 68 More Staffers

Feb 13 2012

• By Cathy Dombrowski and Derrick Gingery

Related Content

GOP Drug Shortage Strategy Pushes FDA Reform, Reimbursement Over Notification

Feb 13 2012

PDUFA V: Can FDA Fight Off Mission Creep This Cycle?

Feb 06 2012

FDA’s Generic Drug Office Goes On Diet Before Swallowing User Fees

Nov 28 2011

FDA Wants Authority To Enforce Track-And-Trace System For Drugs

Sep 19 2011

Priority Review Voucher Value Still Confounds, But Remains An Incentive For Sponsors

Sep 21 2011

Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections

Dec 07 2011

User Fee Triggers Require Care In Unfriendly Budget Environment, Ventimiglia Says

Dec 05 2011

How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique

Jul 18 2011

Related Companies

Novartis AG

Additional Topics

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window